A

Encapsulation into hyaluronic acid-based nanogels improves the selectivity index of the snake cathelicidin Ab-Cath

Nanomedicine Nanotechnology Biology and Medicine, vol. 52, pp. 102694

Abstract

The antimicrobial peptide Ab-Cath, is a promising candidate for development as treatment for antimicrobial resistant (AMR) bacterial infections. Future clinical use is hampered by Ab-Cath's cationic peptidic nature and limited therapeutic window. Here, we evaluated hyaluronic acid-based nanogels for encapsulation of Ab-Cath to circumvent these limitations. Using microfluidics, monodispersed anionic nanogels of 156–232 nm encapsulating >99 % Ab-Cath were prepared. Unprecedented, lyophilization using polyvinyl alcohol and dextran-40 provided Ab-Cath nanogel protection and allowed easy dose adjustment. Lyophilized and redispersed Ab-Cath nanogels were as effective as Ab-Cath solution in killing AMR Staphylococcus aureus, Acinetobacter baumannii and Escherichia coli in biological fluids, and in reducing S. aureus and A. baumannii biofilms. Importantly, encapsulation of Ab-Cath in nanogels reduced Ab-Cath's cytotoxic effects on human fibroblasts by ≥10-fold. Moreover, cutaneous application of Ab-Cath nanogels eliminated bacteria colonizing 3D human skin. These findings affirm the use of nanogels to increase the selectivity index of antimicrobial peptides.

Authors 10

  1. Leiden University Medical Center

    Affiliation as printed

    Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, the Netherlands. Electronic address: M.E.van_Gent@lumc.nl

    Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, the Netherlands

  2. University of Copenhagen

    Affiliation as printed

    Center for Biopharmaceuticals and Biobarriers in Drug Delivery (BioDelivery), Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark

  3. Leiden University Medical Center

    Affiliation as printed

    Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, the Netherlands

  4. Leiden University Medical Center

    Affiliation as printed

    Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, the Netherlands

  5. Leiden University Medical Center

    Affiliation as printed

    Department of Cell and Chemical Biology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands

  6. Leiden University Medical Center

    Affiliation as printed

    Electron Microscopy Facility, Department of Cell and Chemical Biology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands

  7. Leiden University Medical Center

    Affiliation as printed

    Electron Microscopy Facility, Department of Cell and Chemical Biology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands

  8. Leiden University Medical Center

    Affiliation as printed

    Department of Immunology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands

  9. University of Copenhagen

    Affiliation as printed

    Center for Biopharmaceuticals and Biobarriers in Drug Delivery (BioDelivery), Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark

  10. Leiden University Medical Center

    Affiliation as printed

    Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, the Netherlands

Cited by 12 stored of 12

12 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 30